Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Generic Leflunomide vs Arava in Healthy Thai Males
NCT06228443Phase 1Not yet recruiting
- Sponsor
- International Bio Service
- Start
- Apr 2024
- Primary completion
- Apr 2024
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of leflunomide in rheumatoid arthritis (RA) (2 arms), sponsored by International Bio Service. Primary endpoints: Maximum Plasma Concentration and Area Under the Curve 0-72h. Planned start Apr 2024; status: not yet recruiting.
02
Drugs
leflunomide
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT06228443.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06228443.